Glioma
📧 Sign up to get email alerts when something new happens for Glioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-03-31Clinical Trial Update: 131-I-TM-601 Study in Adults With Solid Tumors [Phase 1]
Phase 1 update on the radiopharmaceutical 131I-TM-601 in adults with solid tumors, including breast cancer, non-small cell lung cancer, mela…
-
CLINICAL_TRIALS trial_result · 2009-03-31Clinical Trial Update: Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma. [Phase 1, Phase 2]
Phase 1/2 safety and tolerability study of the radiopharmaceutical 131I-TM-601 in adults with recurrent glioma has completed; the update sum…
-
CLINICAL_TRIALS other · 2009-02-09Clinical Trial Update: Biological Therapy in Treating Patients With Primary or Advanced Glioma [Phase 2]
A Phase 2 study of a biological therapy for glioma (brain tumors) has been suspended.
-
EMA withdrawal · 2008-12-04EMA Application withdrawn: Theraloc (nimotuzumab) — Oncoscience AG
An EMA application for Theraloc (nimotuzumab) by Oncoscience AG has been withdrawn for the glioma indication.
-
CLINICAL_TRIALS trial_result · 2008-07-15Clinical Trial Update: A Phase I Study of ECO-4601 in Patients With Advanced Cancer [Phase 1]
Phase I study of ECO-4601 in patients with advanced cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-06-09Clinical Trial Update: Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy
This clinical trial investigates whether SV2A expression in glioma tissue correlates with the efficacy of levetiracetam in patients with epi…
-
CLINICAL_TRIALS trial_result · 2008-03-21Clinical Trial Update: Cognitive Rehabilitation of Glioma Patients [Phase 3]
This document reports a Phase 3 clinical trial testing cognitive rehabilitation for glioma patients, with the trial status currently unknown…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain Tumors [Phase 1]
Pediatric Phase I trial evaluating RMP-7 in combination with carboplatin for brain tumors (glioma and medulloblastoma) has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Phase I Study of SU101 in Pediatric Patients With Refractory Malignancy [Phase 1]
A Phase I study evaluating SU101 in pediatric patients with refractory glioma or sarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Evaluation of Factors in Human Brain Tumors
A completed NINDS clinical trial evaluated factors in human brain tumors, including glioblastoma, glioma, and pituitary neoplasms.
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: The Role of Gene Changes in Brain Tumor Formation and Growth
Completed National Institute of Neurological Disorders and Stroke study examining how genetic alterations influence glioma development and g…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor
This clinical trial (NCT00001148) completed. It investigated detecting malignant brain tumor cells in the bloodstream during brain tumor sur…
-
CLINICAL_TRIALS withdrawal · 2008-01-03Clinical Trial Update: XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema [Phase 3]
Phase 3 trial of XERECEPT (human corticotropin-releasing factor) in primary glioma patients requiring dexamethasone to treat peritumoral bra…
-
EMA withdrawal · 2007-07-20EMA Application withdrawn: Cerepro (adenovirus-mediated Herpes simplex virus-thymidine kinase gene) — Ark Therapeutics
EMA withdrew the Cerepro gene therapy application for glioma from Ark Therapeutics.